Compare
Aethlon Medical Inc vs Medinotec Inc. vs Autonomix Medical, Inc. vs RenovoRx, Inc.
| Latest fiscal year | Aethlon Medical Inc AEMD | Medinotec Inc. MDNC | Autonomix Medical, Inc. AMIX | RenovoRx, Inc. RNXT |
|---|---|---|---|---|
| Year ended | 2026-03-31 | 2026-02-28 | 2026-03-31 | 2025-12-31 |
| Revenue | n/a | $9.73M | $0 | $1.12M |
| Revenue growth (YoY) | n/a | +6.8% | n/a | n/m |
| Gross margin | n/a | 52.7% | n/a | 70.9% |
| Operating margin | n/a | 11.2% | n/a | n/m |
| Net margin | n/a | 8.2% | n/a | -994.5% |
| Net income | -$7.15M | $794.5K | -$16.71M | -$11.17M |
| EPS (Diluted) | -$10.61 | n/a | n/a | -$0.32 |
| Operating cash flow | -$7.00M | $906.8K | -$12.28M | -$10.97M |
| Free cash flow | -$7.00M | $905.4K | -$12.29M | -$10.97M |
| Cash & equivalents | $5.03M | n/a | $7.00M | $7.02M |
| Total assets | $6.33M | $6.81M | $7.60M | $8.10M |
| Total liabilities | $1.45M | $1.10M | $1.71M | $2.67M |
| Shareholders' equity | $4.89M | $5.71M | $5.89M | $5.42M |
| Return on year-end equity | -146.4% | 13.9% | -283.5% | -206.0% |
| Shares outstanding | 1.57M | 11.76M | 11.41M | 36.61M |
Revenue, most recent five fiscal years
| Fiscal year | Aethlon Medical Inc | Medinotec Inc. | Autonomix Medical, Inc. | RenovoRx, Inc. |
|---|---|---|---|---|
| Latest | $0 Ended 2024-03-31 | $9.73M Ended 2026-02-28 | $0 Ended 2026-03-31 | $1.12M Ended 2025-12-31 |
| 1 year earlier | $574.2K Ended 2023-03-31 | $9.11M Ended 2025-02-28 | $0 Ended 2025-03-31 | $43.0K Ended 2024-12-31 |
| 2 years earlier | $294.2K Ended 2022-03-31 | $5.02M Ended 2024-02-29 | $0 Ended 2024-03-31 | n/a |
| 3 years earlier | $659.1K Ended 2021-03-31 | $999.6K Ended 2023-02-28 | $0 Ended 2023-03-31 | n/a |
| 4 years earlier | $650.2K Ended 2020-03-31 | n/a | n/a | n/a |